<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.huliq.com" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
 <title>Plasma Derived Products</title>
 <link>http://www.huliq.com/tags/plasma-derived-products</link>
 <description>The taxonomy view with a depth of 0.</description>
 <language>en</language>
<item>
 <title>BDI Announces Agreement With Apotex to Distribute HepaGam B</title>
 <link>http://www.huliq.com/22102/bdi-announces-agreement-with-apotex-to-distribute-hepagam-b</link>
 <description>Blood Diagnostics, Inc. (BDI), one of the leading distributors of recombinant and plasma-derived pharmaceutical products, on May 18th announced immediate availability of HepaGam B, the first intravenous hepatitis B immune globulin approved by the FDA. </description>
 <comments>http://www.huliq.com/22102/bdi-announces-agreement-with-apotex-to-distribute-hepagam-b#comments</comments>
 <category domain="http://www.huliq.com/health">Health</category>
 <category domain="http://www.huliq.com/tags/hepatitis-b">hepatitis B</category>
 <category domain="http://www.huliq.com/tags/hepatitis-b-immune-globulin">Hepatitis B immune globulin</category>
 <category domain="http://www.huliq.com/tags/plasma-derived-products">Plasma Derived Products</category>
 <category domain="http://www.huliq.com/tags/recombinant-products">Recombinant Products</category>
 <pubDate>Fri, 18 May 2007 22:02:46 -0500</pubDate>
 <dc:creator>Anastvatz</dc:creator>
 <guid isPermaLink="false">22102 at http://www.huliq.com</guid>
</item>
</channel>
</rss>
